| 10377791 |
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1 |
Maire Eloranta, Leena HIRVELÄ, Lauri Kangas, Pasi Koskimies, Risto Lammintausta |
2019-08-13 |
| 9850272 |
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1 |
Leena HIRVELÄ, Lauri Kangas, Pasi Koskimies, Risto Lammintausta |
2017-12-26 |
| 9663549 |
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase |
Maire Eloranta, Leena HIRVELÄ, Lauri Kangas, Pasi Koskimies, Risto Lammintausta |
2017-05-30 |
| 8288367 |
Substituted estratriene derivatives as 17BETA HSD inhibitors |
Josef Messinger, Uwe Schoen, Heinrich-Hubert Thole, Bettina Husen, Pasi Koskimies |
2012-10-16 |
| 7582677 |
Lignan formulations |
Helena Korte, Veli-Matti Lehtola, Mervi Hiilovaara-Teijo, Markku Ahotupa |
2009-09-01 |
| 7528166 |
Lignan derivatives |
Patrik Eklund, Mervi Hiilovaara-Teijo, Arja Kalapudas, Lauri Kangas, Anna Lindholm +2 more |
2009-05-05 |
| 7524853 |
Compounds and their use in therapy |
Leena Hirvelae, Nina Johansson, Pasi Koskimies, Olli Pentikaeinen, Tommi Nyroenen +10 more |
2009-04-28 |
| 7008666 |
Method of inhibiting overactivity of phagocytes or lymphocytes in an individual |
Markku Ahotupa, John Eriksson, Lauri Kangas, Janne Komi, Merja Perälä +1 more |
2006-03-07 |